GENTILI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 8.680
EU - Europa 5.364
AS - Asia 4.171
SA - Sud America 748
Continente sconosciuto - Info sul continente non disponibili 254
AF - Africa 131
OC - Oceania 11
Totale 19.359
Nazione #
US - Stati Uniti d'America 8.276
FI - Finlandia 1.999
IT - Italia 1.788
SG - Singapore 1.607
CN - Cina 950
BR - Brasile 584
VN - Vietnam 475
HK - Hong Kong 325
DE - Germania 299
PL - Polonia 229
GB - Regno Unito 218
BD - Bangladesh 192
CA - Canada 188
UA - Ucraina 165
FR - Francia 136
JP - Giappone 111
TR - Turchia 109
RU - Federazione Russa 108
SE - Svezia 101
ID - Indonesia 99
NL - Olanda 92
IN - India 87
MX - Messico 73
AR - Argentina 61
ZA - Sudafrica 51
ES - Italia 48
IQ - Iraq 47
LT - Lituania 36
AT - Austria 31
BE - Belgio 28
CO - Colombia 26
PK - Pakistan 25
EC - Ecuador 23
JM - Giamaica 22
CR - Costa Rica 20
VE - Venezuela 19
MA - Marocco 18
MY - Malesia 18
HN - Honduras 17
TT - Trinidad e Tobago 17
CZ - Repubblica Ceca 16
SA - Arabia Saudita 15
NI - Nicaragua 14
SV - El Salvador 14
PR - Porto Rico 13
PE - Perù 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
ET - Etiopia 10
RS - Serbia 10
TH - Thailandia 10
AU - Australia 9
CL - Cile 9
EE - Estonia 9
GT - Guatemala 9
UZ - Uzbekistan 9
DZ - Algeria 8
KE - Kenya 8
TN - Tunisia 8
CW - ???statistics.table.value.countryCode.CW??? 7
IE - Irlanda 7
IL - Israele 7
KR - Corea 7
NP - Nepal 7
RO - Romania 7
BO - Bolivia 6
EG - Egitto 6
IR - Iran 6
JO - Giordania 6
PT - Portogallo 6
PY - Paraguay 6
CH - Svizzera 5
GP - Guadalupe 5
HR - Croazia 5
KG - Kirghizistan 5
AO - Angola 4
GH - Ghana 4
GR - Grecia 4
LB - Libano 4
PH - Filippine 4
AL - Albania 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KZ - Kazakistan 3
MU - Mauritius 3
NG - Nigeria 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
EU - Europa 2
KW - Kuwait 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SC - Seychelles 2
Totale 19.086
Città #
Helsinki 1.910
Ashburn 1.182
Singapore 962
San Jose 790
Ferrara 518
Fairfield 446
Santa Clara 398
Council Bluffs 387
Beijing 352
Woodbridge 342
Hong Kong 315
Chandler 258
Houston 243
New York 238
Warsaw 225
Ann Arbor 212
Seattle 200
Los Angeles 198
Milan 189
Dallas 187
Wilmington 179
Jacksonville 168
Ho Chi Minh City 150
Cambridge 140
Hanoi 105
Tokyo 105
Bologna 97
The Dalles 92
Jakarta 86
Lauterbourg 84
Munich 82
Rome 81
Princeton 69
Boardman 68
Shanghai 66
Nanjing 65
São Paulo 61
Orem 56
Izmir 54
Montreal 54
Buffalo 51
Phoenix 51
Toronto 51
Chicago 47
Turku 46
San Diego 45
Mexico City 44
Denver 40
London 40
San Francisco 40
Brooklyn 39
Frankfurt am Main 34
Turin 32
Johannesburg 31
Da Nang 30
Atlanta 29
Naples 29
Brussels 27
Ferrara di Monte Baldo 26
Moscow 24
Haiphong 22
Hefei 22
Washington 22
Stockholm 21
Boston 19
Chennai 19
Nanchang 19
North Bergen 19
Nuremberg 19
Rio de Janeiro 19
Verona 19
Poplar 18
Curitiba 17
Redwood City 17
San José 17
Baghdad 16
Dong Ket 16
Florence 16
Shenyang 16
Amsterdam 15
Changsha 15
Genoa 15
Bari 14
Falls Church 14
Manchester 14
Vienna 14
Columbus 13
Kingston 13
Managua 13
Palermo 13
Addison 12
Belo Horizonte 12
Chongqing 12
Philadelphia 12
Pittsburgh 12
San Salvador 12
Vilnius 12
Catania 11
Dhaka 11
Falkenstein 11
Totale 12.793
Nome #
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.049
Pazienti con sclerosi multipla presentano una risposta antivirale alterata nei confronti dell’infezione da herpesvirus riconducibile all’attività inibitoria di KIR2DL2 sulle cellule natural killer. 607
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 377
Conjugation of LasR Quorum-Sensing Inhibitors with Ciprofloxacin Decreases the Antibiotic Tolerance of P-aeruginosa Clinical Strains 330
Generalized eruptive keratoacanthoma of the Grzybowski type: some considerations on treatment and pathogenesis 316
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 310
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 306
An accurate and reliable real time SNP genotyping assay for the HLA-G +3142 bp C>G polymorphism 299
Impact of soluble HLA-G levels and endometrial NK cells in uterine flushing samples from primary and secondary unexplained infertile women 297
HHV-6A infection of endometrial epithelial cells affects immune profile and trophoblast invasion 296
HUMAN HERPESVIRUS 8 UPREGULATES ACTIVATING TRANSCRIPTION FACTOR 4 (ATF4) and REAL TIME PCR TO ASSESS TOTAL BACTERIAL LOAD IN CHRONIC WOUNDS. 292
HHV-6A infection of endometrial epithelial cells induces increased endometrial NK cell-mediated cytotoxicity 265
Presence of HHV-6A in endometrial epithelial cells from women with primary unexplained infertility 262
KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections 257
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 255
Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing 250
Altered Natural Killer cells response to herpesvirus infection in Multiple Sclerosis involves KIR2DL2 expression 249
Helix aspersa muller mucus (Helixcomplex ®) interferes with Herpes simplex 1 virus infection 245
HelixComplex snail mucus as a potential technology against O3 induced skin damage 242
Detection of HHV-6-specific mRNA and antigens in PBMCs of individuals with chromosomally integrated HHV-6 (ciHHV-6) 241
Detection of human herpesvirus 8 sequences in cutaneous cherry angiomas 240
Viral load difference between symptomatic and asymptomatic COVID-19 patients: Systematic review and meta-analysis 237
The impact of HLA-G levels and endometrial NK cells in the uterine flushing from primary and secondary unexplained female infertility 234
Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome 232
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway 231
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 230
Comparison Between Moxifloxacin and Chloramphenicol for the Treatment of Bacterial Eye Infections 224
HLA-G influences nasal polyp relapse in HPV positive patients. 221
DNA Sensors’ Signaling in NK Cells During HHV-6A, HHV-6B and HHV-7 Infection 217
DAG-MAG-BHB: A Novel Ketone Diester Modulates NLRP3 Inflammasome Activation in Microglial Cells in Response to Beta-Amyloid and Low Glucose AD-like Conditions 213
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 206
Aerosols modification with H2O2 reduces airborne contamination by dental handpieces 203
Activating Transcription Factor 4 (ATF4) promotes HIV-1 activation 202
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 201
TLR3 and TLR7 RNA Sensor Activation during SARS-COV-2 Infection 201
Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed™ Sorbact™ 199
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 199
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis 197
Glicopro, novel standardized and sterile snail mucus extract for multi-modulative ocular formulations: New perspective in dry eye disease management 196
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 186
Studio delle alterazioni nelle risposte antiviralidell'immunità innata in pazienti con Sclerosi Multipla 185
Helix aspersa muller mucus (Helixcomplex ®) p41 protein prevents Pseudomonas aeruginosa growth and promotes mammalian bronchial epithelial cell proliferation 183
Implication of HLA-G 3' untranslated region polymorphisms in human papillomavirus infection. 182
Design of liposomes carrying HelixComplex Snail Mucus: preliminary studies 179
Human herpesvirus 7, Epstein-Barr virus and human cytomegalovirus in periodontal tissues of periodontally diseased and healthy subjects 178
Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage 178
Ozonated Oil in Liposome Eyedrops Reduces the Formation of Biofilm, Selection of Antibiotic-Resistant Bacteria, and Adhesion of Bacteria to Human Corneal Cells 177
Synthesis of naringenin-betaine cocrystal by gas antisolvent technique and cell models for in vitro permeation studies 176
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 176
Alterazioni dell’immunità innata in risposta alla infezione con Herpevirus in pazienti con Sclerosi Multipla 175
Covid-19 ocular prophylaxis: The potential role of ozonated-oils in liposome eyedrop gel 175
HHV-6A Infection of Endometrial Epithelial Cells Affects miRNA Expression and Trophoblast Cell Attachment 172
Late-onset intrauterine growth restriction and HHV-6 infection: A pilot study 171
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2 170
The U94 gene of human herpesvirus 6: a narrative review of its role and potential functions 166
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 165
Non-classical HLA class I molecules and their potential role in viral infections 165
ERMES: Emilia-Romagna multiple sclerosis. Regional network for implementing a biological bank to identify markers of disease activity related to clinical variables. KIR2DL2 expression alters natural killer cells response to herpesvirus infection in multiple sclerosis patients 165
Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion 163
Characterization of Neochloris oleoabundans under Different Cultivation Modes and First Results on Bioactivity of Its Extracts against HCoV-229E Virus 161
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 161
Transparent Polymeric Formulations Effective against SARS-CoV-2 Infection 159
JG26 attenuates ADAM17 metalloproteinase-mediated ACE2 receptor processing and SARS-CoV-2 infection in vitro 154
Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virus 152
HHV-6A infection induces amyloid-beta expression and activation of microglial cells 148
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 'cytokine storm' 146
Role of KIR Receptor in NK Regulation during Viral Infections 146
Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells 145
DNA-Based Technology for Herpesvirus Detection 144
Soluble HLA-G pre-transplant levels to identify the risk for development of infection in heart transplant recipients 136
Hydroxypropyl-Methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: In Vitro and Clinical Study 134
Characterization of Neochloris oleoabundans under different cultivation modes and first results on bioactivity of its extracts against HCoV-229E virus 134
HHV-6A infection of microglial cells induces the expression of Alzheimer’s disease risk factors 125
Infection and HLA-G molecules in nasal polyposis. 121
null 121
L'HERPESVIRUS UMANO DI TIPO 8 (HHV-8) INCREMENTA IL FATTORE CELLULARE TRASCRIZIONALE ATF4 120
SARS-CoV-2 presence in recreational seawater and evaluation of intestine permeability: experimental evidence of low impact on public health 119
Studio pilota prospettico sull’utilizzo di una medicazione anti-infettiva di nuova concezione:correlazione tra risultati clinici e dati microbiologici 117
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis 110
Studio pilota prospettico sull’utilizzo di una medicazione anti-infettiva di nuova concezione: correlazione tra risultati clinici e dati microbiologici con PCR real-time. 109
null 107
Efficacy of personal protective equipment against coronavirus transmission via dental handpieces 103
Efficacy of personal protective equipment and H2 O2 -based spray against coronavirus in dental setting 100
KIR2DL2 expression alters natural killer cells response to herpesvirus infection in multiple sclerosis patients. 95
null 92
Riduzione della carica batterica totale quantificata mediante analisi biomolecolare in ulcere infette trattate con Cutimed® Sorbact®. 88
Implication of HLA-C and KIR Alleles in Human Papillomavirus Infection and Associated Cervical Lesions. 82
SCREENING ANALYSIS OF THE PROBIOTIC BACTERIA Phaeobacter inhibens ON LARVAE OF MANILA CLAM (Ruditapes philippinarum), FROM GAMETE EMISSION TO METAMORPHOSIS 81
Genome sequences of segmented filamentous bacteria in animals Implications for human research 79
Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions. 72
Roles of full-length and Δα1 HLA-G isoforms in NK-cell regulation and vascular SARS-CoV-2 infection 56
null 54
null 53
null 51
null 48
Correction: Design of Liposomes Carrying HelixComplex Snail Mucus: Preliminary Studies (Molecules, (2021), 26, 16, (4709), 10.3390/molecules26164709) 21
Totale 19.359
Categoria #
all - tutte 81.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022538 0 0 0 54 41 37 39 31 36 51 55 194
2022/2023782 90 75 44 70 86 79 67 51 102 26 61 31
2023/2024816 52 76 55 31 81 118 31 56 13 44 39 220
2024/20252.697 92 103 231 176 250 254 112 149 404 290 359 277
2025/20269.057 701 323 514 787 995 473 971 410 2.490 760 462 171
2026/20272.194 345 445 656 748 0 0 0 0 0 0 0 0
Totale 19.359